This narrative review examines the antimicrobial properties of selenium nanoparticles (SeNPs) based on published preclinical research.
Materials · 5 authors, 3 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review examines the antimicrobial properties of selenium nanoparticles (SeNPs) based on published preclinical research.
This narrative review examines the antimicrobial properties of selenium nanoparticles (SeNPs) based on published preclinical research. It details various synthesis methods (chemical, biological, physical), noting that synthesis method influences nanoparticle size, shape, and minimum inhibitory concentration (MIC). The review summarizes SeNPs' demonstrated antibacterial, fungicidal, and antiviral activities in laboratory settings, highlighting their potential as an alternative to combat antimicrobial resistance. Limitations include the preclinical nature of the evidence and the acknowledged need for more thorough investigation of the chronic cytotoxicity of SeNPs.